Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Loperamide × 90 days × Clear all

Sponsor

Conditions

Diarrhea 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Gliosarcoma 1 Glioblastoma 1 Exanthema 1 Colitis 1 Carcinoma in Situ 1

Interventions

pembrolizumab 41 Carboplatin 22 Paclitaxel 21 Specimen Handling 16 Biopsy 14 Magnetic Resonance Spectroscopy 13 Cyclophosphamide 12 Capecitabine 10 130-nm albumin-bound paclitaxel 9 olaparib 8 Doxorubicin 8 Albumin-Bound Paclitaxel 8 Gemcitabine 7 eribulin 6 sacituzumab govitecan 5 Taxes 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Standard of Care 4 Nivolumab 4 Injections 4 Drug Therapy 4 Docetaxel 4 liposomal doxorubicin 3 durvalumab 3 capivasertib 3 X-Rays 3 Radiation 3 Platinum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡